Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
Scientific Reports|August 22, 2025
Non-canonical G<sub>q</sub> activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulationsPaulina Dragan, Valerie Gratio, Thierry Voisin, et al.Pharmaceutics|February 25, 2023
Chemokine Receptors-Structure-Based Virtual Screening Assisted by Machine LearningPaulina Dragan, Matthew Merski, Szymon Wiśniewski, et al.Plos One|January 26, 2019
Potential off-target effects of beta-blockers on gut hormone receptors: In silico study including GUT-DOCK-A web service for small-molecule dockingPawel Pasznik, Ewelina Rutkowska, Szymon Niewieczerzal, et al.Methods in Molecular Biology (Clifton, N.J.)|December 1, 2017
Approaches for Differentiation and Interconverting GPCR Agonists and AntagonistsPrzemysław Miszta, Jakub Jakowiecki, Ewelina Rutkowska, et al.Nucleic Acids Research|May 23, 2018
GPCRM: a homology modeling web service with triple membrane-fitted quality assessment of GPCR modelsPrzemyslaw Miszta, Pawel Pasznik, Jakub Jakowiecki, et al.Cellular Signalling|September 29, 2004
Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulationIngrid Langer, Patrick RobberechtBritish Journal of Pharmacology|December 15, 2024
Pharmacodynamics of the orexin type 1 (OX<sub>1</sub>) receptor in colon cancer cell models: A two-sided nature of antagonistic ligands resulting from partial dissociation of GqValérie Gratio, Paulina Dragan, Laurine Garcia, et al.British Journal of Pharmacology|June 20, 2006
Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)Ingrid Langer, Nathalie Gaspard, Patrick RobberechtJournal of Molecular Endocrinology|April 12, 2005
Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptorIngrid Langer, Christelle Langlet, Patrick RobberechtJournal of Molecular Modeling|March 3, 2011
Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 ARDorota Latek, Michal Kolinski, Umesh Ghoshdastider, et al.Pageof 8